Name | acenocoumarol |
---|---|
Synonyms |
UNII:I6WP63U32H
4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one Trombostop EINECS 205-807-3 MFCD00137816 2H-1-Benzopyran-2-one, 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]- 2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)- 2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-, (±)- 3-(a-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one acenocoumarol 3-(a-p-Nitrophenyl-b-acetylethyl)-4-hydroxycoumarin |
Description | Acenocoumarol is an anticoagulant that functions as a Vitamin K antagonist. |
---|---|
Related Catalog |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 592.7±50.0 °C at 760 mmHg |
Melting Point | 196-199ºC |
Molecular Formula | C19H15NO6 |
Molecular Weight | 353.326 |
Flash Point | 312.3±30.1 °C |
Exact Mass | 353.089935 |
PSA | 113.33000 |
LogP | 3.15 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.656 |
Water Solubility | DMSO, heptane and xylene: ≥17mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P301 + P312 + P330-P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Phrases | 63-22-36/37/38 |
Safety Phrases | 26-36/37 |
RIDADR | UN 2811 |
RTECS | GN4900000 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2932209090 |
~% 152-72-7 152-72-7 |
Literature: Angewandte Chemie - International Edition, , vol. 42, # 40 p. 4955 - 4957 |
~% 152-72-7 152-72-7 |
Literature: Bulletin of the Korean Chemical Society, , vol. 33, # 6 p. 1825 - 1826 |
~% 152-72-7 |
Literature: Tetrahedron Asymmetry, , vol. 12, # 5 p. 707 - 709 |
~% 152-72-7 |
Literature: Tetrahedron Asymmetry, , vol. 12, # 5 p. 707 - 709 |
HS Code | 2932209090 |
---|---|
Summary | 2932209090. other lactones. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |